Category: Science Explained
Withanolides are the steroidal lactones that give ashwagandha most of its activity. Knowing what they are, and how withaferin A differs from withanolide A, explains why the percentage printed on the label is the number that matters.
Category: Science Decoded | Reading time: ~9 min | Level: Intermediate
Pick up two tubs of ashwagandha and the difference between them is usually invisible from the front of the label. Both say ashwagandha. Both promise calm. One might cost three times the other. The information that actually separates them is a small line, often on the back, giving a percentage of something called withanolides. That number is doing more work than the entire marketing panel, and most people walk past it because nobody has explained what it means.
Withanolides are the reason ashwagandha does anything measurable. They are also the reason a cheap non-standardised powder and a studied extract are not the same product wearing different prices. Understanding the compound family, and in particular why two of its members, withaferin A and withanolide A, are not interchangeable, turns that little percentage from mystery text into the single most useful thing on the tub. So here is what withanolides are and how to read them.
Withanolides are the steroidal lactone compounds in ashwagandha responsible for most of its activity [1]. Steroidal lactone describes their chemistry: they share a steroid-like backbone, similar in shape to the body's own steroid hormones, combined with a lactone ring. They are the main active constituents of the plant, which means the effects ashwagandha is studied for are largely attributed to this compound family rather than to any single ingredient [1].
The one mechanism sentence to keep is this: because withanolides are shaped like steroids, they can interact with hormonal and stress-response systems, and the best-evidenced result of that is modulation of the HPA axis, the chain that controls cortisol [1][3]. That structural resemblance is the thread running through ashwagandha's effects on stress, sleep and mood. When a product is standardised to a withanolide percentage, this is the family it is measuring.
The word withanolides is plural for a reason, and treating the whole family as one compound is where a lot of confusion starts. Two members illustrate why the distinction matters.
Withanolide A is associated with ashwagandha's calming, stress-related actions. It is one of the compounds linked to effects on the GABA system, the brain's inhibitory signalling, which contributes to the anxiolytic and settling effects reported clinically [1]. It sits within the compound mix of the root-based extracts that have been studied for stress and sleep, and it is broadly the kind of withanolide you are looking for if calm is the goal.
Withaferin A is a different animal. It is a more chemically reactive withanolide, and its research profile is largely preclinical: it has been studied for anti-inflammatory and anti-cancer activity in laboratory and animal models through pathways separate from the stress axis [1]. Importantly, withaferin A is more concentrated in ashwagandha leaf than in root. That single fact explains a lot about product differences, because a root-only extract and a root-plus-leaf extract carry different balances of these compounds, and therefore different evidence and different intended uses.
So the family is not uniform. A high total withanolide figure could reflect a calming, root-based profile or a leaf-heavy profile richer in the more reactive withaferin A. The name on the label is the same; the compound mix underneath is not.
Now the practical payoff. The withanolide percentage is the closest thing ashwagandha has to a potency reading, and it is what connects a real product to the doses used in research.
Raw ashwagandha root powder is naturally low in withanolides. Standardised extracts concentrate them to a stated percentage, and root-only extracts are commonly standardised to around 5 per cent [1]. That concentration is what allows a capsule to deliver an amount of active compound comparable to what a trial used. Clinical studies for stress used specific standardised extracts at specific doses, and the withanolide percentage is the bridge between those studies and the tub in your hand [3]. Without a stated percentage, you cannot know how much active compound you are taking, which is precisely why a generic non-standardised powder has no reliable basis for a specific dose.
The tempting next move is to chase the biggest percentage, and that is where people go slightly wrong. A higher figure means more concentrated withanolides, but it does not tell you the profile, the ratio of specific compounds, or whether the extract matches one with human trials behind it. A root-only extract at 5 per cent with real stress-and-sleep evidence may be a better choice than a higher-percentage leaf-containing extract studied for something else. The number matters, but the number plus a named, studied extract matters far more. The percentage is how you match a dose; the named extract is how you match the evidence.
If you are choosing or comparing ashwagandha, use the withanolide percentage as your first filter and the named extract as your second. A product that states a withanolide percentage is measured and dosable; a product that does not is a guess. That alone rules out much of the cheapest, vaguest end of the market.
Then look for the extract, not just the number. The strongest human evidence for stress and sleep is attached to specific standardised root extracts, so a product that names such an extract and states its withanolide percentage lets you match both the dose and the evidence [3]. Do not be seduced by an unusually high percentage on its own, and do not assume a leaf-containing, withaferin-A-rich extract is the same product as a calming root extract, because they are studied for different things.
Finally, set the timescale withanolides actually work on. The stress effects of these extracts emerge over roughly 60 days in trials, not in a few doses [3]. A fair trial of a well-chosen product is measured in weeks, and the percentage on the label is only useful if you give the compound time to do what it was standardised to do.
Understanding withanolides does not change ashwagandha's contraindications, and a higher potency is a reason to respect them more, not less.
Ashwagandha is contraindicated in pregnancy and not advised while breastfeeding. It affects thyroid hormones, making it a concern in thyroid conditions and with thyroid medication, and it is immunomodulatory, so it is generally avoided in autoimmune conditions without oversight. It also carries a rare liver signal. Because leaf-containing extracts are richer in the more reactive withaferin A, the general cautions apply at least as firmly to them. A stated withanolide percentage tells you about potency; it does not tell you the product is right for your situation.
Pregnant, breastfeeding, or on medication? Check with a healthcare professional first.
Our view is that the withanolide percentage, and the named extract behind it, is where honesty in an ashwagandha product lives. A tub that hides its potency is asking you to trust the front panel; a tub that states it is inviting you to check the evidence.
That is why the ashwagandha we offer as a stress tonic is described by the specific studied preparation and its withanolide standardisation, and framed exactly as the evidence allows: moderate support for a stressed, cortisol-elevated system over about two months. If you want the fuller picture, our complete ashwagandha guide walks through the trials, and our explainers on KSM-66 and on standardised extracts show how the percentage becomes a real, matchable dose.
1. Mikulska P, et al. (2023). Ashwagandha (Withania somnifera) current research on the health-promoting activities: a narrative review. Pharmaceutics, 15(4):1057. PMC10385836. Review of ashwagandha constituents including withanolide A and withaferin A. 2. National Center for Complementary and Integrative Health (2023). Ashwagandha. Government evidence synthesis; stress evidence promising but not settled; safety cautions. 3. Chandrasekhar K, et al. (2012). A prospective, randomised, double-blind, placebo-controlled study of ashwagandha root extract in reducing stress and anxiety, 64 adults. Indian Journal of Psychological Medicine. Standardised extract dosed against withanolide content; 27.9 per cent cortisol reduction over 60 days.
Withanolides are a family of naturally occurring steroidal lactones, compounds with a steroid-like backbone, found in ashwagandha and some related plants. They are the main active constituents, meaning most of ashwagandha's studied effects are attributed to them. Their steroid-like structure is thought to be why they can interact with hormonal and stress-response systems in the body. When a product is standardised to a withanolide percentage, it is being measured by the concentration of this compound family.
They are two distinct withanolides with different profiles. Withanolide A is associated with ashwagandha's calming and stress-related actions, including effects on the GABA system, and features in the compound mix of root-based extracts studied for stress and sleep. Withaferin A is a more chemically reactive withanolide studied largely in preclinical anti-inflammatory and anti-cancer research, and it is more concentrated in leaf material. They are not interchangeable, and a product's balance between them depends on which plant parts it uses.
Because it is the closest thing to a potency measure on the label. Raw ashwagandha root powder is naturally low in withanolides, whereas standardised extracts concentrate them to a stated percentage, which lets a dose be matched to what clinical trials used. Without a stated percentage you cannot know how much active compound you are getting, so a generic non-standardised powder has no reliable basis for a specific dose. The percentage is how the studied doses translate to a real product.
Not necessarily. A higher percentage means more concentrated active compounds, but the profile matters too: which withanolides are present and in what ratio, and whether the extract matches the one used in trials. A root-only extract and a root-plus-leaf extract can both carry a high percentage while having quite different compound mixes and different evidence behind them. Chasing the single biggest number can miss the point, which is matching the specific studied preparation.
The best-evidenced mechanism is modulation of the HPA axis, the stress-hormone chain, which is how ashwagandha is proposed to reduce elevated cortisol in stressed people. Withanolide A also appears to interact mildly with the GABA system, contributing to a calming effect. In preclinical work, withaferin A shows anti-inflammatory and other activity through separate pathways. So withanolides are not a single action but a family of related compounds hitting several systems, which is why ashwagandha's effects span stress, sleep and mood.
Ashwagandha contains a range of withanolides, and dozens have been described across the plant, though only a few are well studied. The exact mix varies with the plant part, growing conditions and extraction method, which is part of why standardisation exists. For practical purposes, what matters is not counting them but knowing the total withanolide percentage a product is standardised to and which studied extract it corresponds to.
Yes. Withanolides are found across several plants in the nightshade family, not only ashwagandha, though ashwagandha is by far the most studied source and the one supplements are built around. Because the compound family is shared, the name withanolide describes a chemical class rather than something unique to a single species. In a supplement context, though, withanolides almost always means ashwagandha.
It is a meaningful and typical figure for a root-only extract, and it tells you the product is measured and dosed against a known potency, which is a good sign. The more useful question is which extract it is and whether that extract has human trials behind it, because a stated percentage plus a studied preparation is what lets you match a trial-level dose. A percentage with no named, studied extract is better than nothing, but weaker than a percentage tied to real evidence.
For a standardised root-based stress or sleep extract, withaferin A is present at low levels and is not the reason you would take it. It is more concentrated in leaf material, so root-plus-leaf extracts carry more of it. Most people using ashwagandha for stress do fine, but withaferin A is chemically reactive and studied mostly in preclinical settings, which is one more reason the general contraindications, pregnancy, thyroid and autoimmune conditions, deserve respect. If in doubt, check with a clinician.
In practice, no, and it would not be wise. The clinical evidence is for whole standardised extracts, which contain a full profile of withanolides and other constituents in the proportions that were actually studied, not for isolated single compounds in general wellness use. Buying a specific studied extract gives you the mix the trials tested. Chasing an isolated withanolide leaves the evidence behind, which defeats the point of standardisation.